Improving Management of Chest Pain with a High Sensitivity Troponin-Based Protocol
Kristin Lohr1, Colleen O'Connor1, Timothy Shapiro2
1Department of Hospital Medicine, Main Line Health-Lankenau Medical Center, Wynnewood, PA.
Insights
Implementing a high-sensitivity troponin assay and protocol significantly reduced emergency department length of stay and hospital admissions for chest pain patients. This approach also decreased unnecessary cardiac testing, improving efficiency and patient care.
Area of Science:
- Emergency Medicine
- Cardiology
- Clinical Diagnostics
Background:
- Chest pain is a frequent emergency department (ED) complaint, necessitating accurate and efficient diagnosis of cardiac conditions like myocardial infarction.
- Traditional troponin assays have limitations in sensitivity and speed, impacting patient disposition and diagnostic timelines.
- High-sensitivity troponin (hs-cTn) assays offer improved detection at lower levels, potentially accelerating diagnosis and management.
Purpose of the Study:
- To implement and evaluate a quality improvement project for managing chest pain patients in an ED setting.
- To assess the impact of a high-sensitivity troponin assay combined with a risk prediction algorithm on patient care and resource utilization.
- To address barriers to adoption and optimize the workflow for chest pain evaluation.
Main Methods:
- A community-academic health system implemented a standardized protocol for chest pain workup utilizing a high-sensitivity troponin assay and a risk prediction algorithm (Heart, EKG, Age, Risk factor, Troponin score).
- Key stakeholders identified and addressed barriers including provider strategy, electronic medical record integration, and cardiology service capacity.
- Interventions included stakeholder buy-in, regular data reporting, team meetings, and comprehensive education to drive changes in practice.
Main Results:
- A 12-month post-implementation period involving 3293 patients showed a significant decrease in mean ED length of stay for chest pain from 297 to 274 minutes (P=0.03).
- Hospital observation admissions for chest pain decreased from 23% to 14% (P<0.001), alongside reductions in stress tests (12 to 3/month), echocardiograms (61 to 46/month), cardiology consultations (125 to 81/month), and cardiac catheterizations (41 to 32/month).
- Significant reductions in testing and admissions were observed across multiple cardiac diagnostic modalities (P<0.001 for most).
Conclusions:
- Implementing a standardized chest pain management protocol with a high-sensitivity troponin assay and risk score effectively reduced ED length of stay and hospital observation admissions.
- The protocol led to a significant decrease in unnecessary cardiac testing and consultations, optimizing resource allocation.
- Standardized protocols and physician leadership are high-impact interventions for improving chest pain management in the ED.
Abstract:
Chest pain is one of the most common presenting complaints to emergency departments in the United States, and management centers on identifying myocardial infarction or other forms of rare but problematic cardiac diagnoses. The high-sensitivity troponin assay can detect abnormal troponin elevations at 10- to 100-fold lower levels compared with traditional troponin assays and thus can allow faster time to disposition and diagnosis, yet adoption has not been universal. Implementing a high-sensitivity troponin protocol with a risk prediction algorithm can decrease the numbers of patients admitted, reduce unnecessary testing, and shorten patient stays in the emergency department. This quality improvement project was undertaken in a community-academic health system lacking a system-wide protocol to workup patients presenting with chest pain to the emergency department. Key stakeholders evaluated multiple barriers and identified measures, planned implementation of the new assay and its associated algorithm, led postimplementation data monitoring and analysis, and delivered progress reports to organizational leaders. Chest pain admissions were managed by hospitalists in the absence of a cardiology inpatient service. The most important barriers were found to be individual provider strategy, electronic medical record design, and the lack of capacity for cardiology evaluations in both inpatient and outpatient settings. Stakeholder buy-in, monthly data reports, team meetings, and widespread education were used to support the changes in ordering patterns and evaluation. Postimplementation, 3293 patients were assessed over a 12-month period. Baseline mean length of stay for chest pain in the emergency department decreased from 297 minutes (SD, 53) to 274 minutes (SD, 33; P = 0.03). Hospital chest pain observation admissions decreased from 23% to 14% of patients presenting with chest pain ( P <0.001). Stress tests ordered for observation patients decreased from 12 per month to 3 ( P <0.001). Similarly, in observation patients, echocardiograms decreased from 61 to 46 per month ( P <0.001), cardiology consultation decreased from 125 per month to 81 ( P <0.001), and cardiac catheterization decreased from 41 per month to 32 following the intervention ( P = 0.003). Developing a standardized management protocol and selecting physician leaders to maintain and revise protocols were high-impact, low to moderate-effort interventions resulting in significant changes in practice. This study demonstrated that a high-sensitivity troponin assay, combined with a chest pain clinical management protocol based on the Heart, EKG, Age, Risk factor, Troponin score, was able to achieve a reduction in emergency department length of stay, a decrease in hospital observation admissions, and reduced cardiac testing in this patient population.
More Related Videos
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
